Scrip 100: Buzzing biotechs outrace sluggish pharma
This article was originally published in Scrip
Executive Summary
When Brett Chase dived into the newest Scrip 100 rankings he found the ground appear to slip beneath big pharma’s feet, as its nimble biotech neighbor whizzes past, fuelled by key acquisitions and big sales.